| 摘要: |
| 目的 分析药物性肝损伤的发生特点和高风险因素,探讨医疗机构DILI 监测路径的建立。方法 对山东省药品不良反应监测中心数据库中2013年-2018年7月31日年5 066例和山东第一医科大学第二附属医院2016-2017年可疑DILI患者的181份的相关影响因素进行统计分析。结果 患者年龄以40-59岁患者居多;涉及药品中抗感染类药物占比最大;患者的体重、潜伏期、药品种类和原患疾病是发生严重DILI的影响因素。结论 根据药物性肝损伤发生特点和影响因素,探讨建立医疗机构药物性肝损伤的监测路径,有利于降低药物性肝损伤发生的风险。 |
| 关键词: 医疗机构 药物性肝损伤 监测路径 |
| DOI:10.13506/j.cnki.jpr.2022.08.014 |
| 基金项目: |
|
出版日期:2022-08-25
|
|
| Discussion on monitoring pathway of drug induced liver injury in medical institutions |
| XU Lili1,TIAN Yuejie1,SU Fengyun2,XIE Yanjun1,LI Xia1 |
| (1.Shandong Provincial Center for ADR Monitoring, Jinan 250014, China;2.The Second Affiliated Hospital of Shandong First Medical University,Taian 271000, China) |
| Abstract: |
| Objective To analyze the characteristics and high risk factors of drug-induced liver injury, and to explore the establishment of DILI monitoring path in medical institutions. Methods we statistically analyzed the related influencing factors of 5 066 suspected DILI patients from the database of ADR Monitoring Center between January 1,2013 and July 31,2018 and 181 suspected DILI patients between January 1,2016 to December 31, 2017 in the Second Affiliated Hospital of Shandong First Medical University. Results Most patients aged 40~59 years; the largest proportion of anti-infective drugs involved; the patient's weight, latency, drug type and primary disease were the influencing factors of severe DILI. Conclusion According to the characteristics and influencing factors of drug-induced liver injury, the establishment of a monitoring path for drug-induced liver injury in medical institutions is conducive to reducing the risk of drug-induced liver injury. |
| Key words: Medical institutions Drug induced liver injury Monitoring pathway |